
Results
2
Companies that has zero debt on their balance sheet and is forecast to grow at an exponential rate in the future.
2 companies
Krystal Biotech
Market Cap: €8.6b
A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.
1KRYS
€261.70
7D
-0.6%
1Y
124.5%
Corcept Therapeutics
Market Cap: €7.6b
A biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
1CORT
€61.98
7D
11.4%
1Y
1.8%